Speeding up European clinical trial regulation
When the European Commission announced the long-awaited revision of the European clinical trials regulation on 17 July 2012, it was…
All articles by Elisabeth Fisher
Elisabeth Fisher
-
-
Mobile revolution: how have drug developers embraced smart device technology?
As a conservative industry, Big Pharma is usually not an early adopter of new technologies. Recently, however, there have been…
-
Positive results for Lundbeck’s schizophrenia drug trial
Danish pharmaceutical company Lundbeck and its Japanese partner Otsuka have announced successful results from a Phase 3 clinical trial evaluating…
-
Plasma-based virus treatment: Q&A with Max-Planck-Institut’s Julia Zimmerman
When, in late 2011, news became public that researchers had found a way to block adenoviruses by using plasma to…
-
Curing addiction: vaccines to end drug abuse
The idea of vaccinating drug addicts against substance abuse is nothing new. In fact, researchers have been intrigued for nearly…
-
Diminishing vaccine wastage: next-gen of temperature-controlled packaging
The World Health Organisation (WHO) estimates the global vaccine wastage currently amounts to 50% for lyophilised and to 25% for…
-
UK Budget 2012: the pharmaceutical industry reacts
Association of the British Pharmaceutical Industry (ABPI) chief executive Stephen Whitehead:"The measures announced in the budget statement will help improve…
-
UK Budget 2012: boosting pharmaceutical research
Against the background of an economy struggling to recover from one of the deepest recessions in history, UK Chancellor George…
-
Track and trace: Europe’s battle against falsified drugs
With the approval of the Falsified Medicine Directive in February 2011, the European Union (EU) has finally made genuine steps…
-
Medical cargo theft: securing the supply chain
Once a clinical trial gets on track and patient recruitment has started, the main concern for drug firms is to…